↓ Skip to main content

Real-World Cost-Effectiveness of Oxaliplatin in Stage III Colon Cancer: A Synthesis of Clinical Trial and Daily Practice Evidence

Overview of attention for article published in PharmacoEconomics, May 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

policy
1 policy source

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
46 Mendeley
Title
Real-World Cost-Effectiveness of Oxaliplatin in Stage III Colon Cancer: A Synthesis of Clinical Trial and Daily Practice Evidence
Published in
PharmacoEconomics, May 2013
DOI 10.1007/s40273-013-0061-6
Pubmed ID
Authors

Chantal W. M. van Gils, Saskia de Groot, William K. Redekop, Miriam Koopman, Cornelis J. A. Punt, Carin A. Uyl-de Groot

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 2%
Unknown 45 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 17%
Student > Ph. D. Student 8 17%
Student > Doctoral Student 5 11%
Student > Bachelor 5 11%
Student > Master 5 11%
Other 6 13%
Unknown 9 20%
Readers by discipline Count As %
Medicine and Dentistry 19 41%
Economics, Econometrics and Finance 5 11%
Pharmacology, Toxicology and Pharmaceutical Science 4 9%
Agricultural and Biological Sciences 2 4%
Nursing and Health Professions 1 2%
Other 4 9%
Unknown 11 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 February 2020.
All research outputs
#7,428,765
of 22,710,079 outputs
Outputs from PharmacoEconomics
#842
of 1,814 outputs
Outputs of similar age
#65,217
of 193,636 outputs
Outputs of similar age from PharmacoEconomics
#13
of 28 outputs
Altmetric has tracked 22,710,079 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,814 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.6. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 193,636 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.